The Company successfully enrolled 52 patients in the study, 18 fewer than initially planned, in a study design modification that received a No Objection Letter ('NOL') from
(C) 2023 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 USD | -1.96% | +6.71% | +26.72% |
The Company successfully enrolled 52 patients in the study, 18 fewer than initially planned, in a study design modification that received a No Objection Letter ('NOL') from
(C) 2023 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.4 AUD | +2.19% | +2.19% | 153M | ||
0.175 USD | -1.96% | +6.71% | 31.18M | ||
1st Jan change | Capi. | |
---|---|---|
+26.72% | 31.18M | |
+19.98% | 43.67B | |
+20.67% | 22.51B | |
+14.56% | 14.6B | |
+14.32% | 13.74B | |
+44.72% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.39% | 5.42B |